Literature DB >> 10662557

Sampling of Aspergillus spores in air.

G Morris1, M H Kokki, K Anderson, M D Richardson.   

Abstract

Nosocomially acquired aspergillosis typically occurs in the setting of treatment for leukaemia or other haematological malignancy. As Aspergillus species can be readily found in the environment, it has been widely believed that aspergillosis occurs as a consequence of exogenous acquisition of the fungus. Stringent environmental controls in transplant units have included high-efficiency air filtration, positive-pressure ventilation and frequent room air changes. Although there have been several well-documented examples of aspergillosis outbreaks as a result of hospital demolition and reconstruction, it has not always been possible to demonstrate elevated spore counts in clinical areas during building work. The sampling of air for Aspergillus is very problematic. Careful attention must be given to the design of air sampler, sampling protocols and an understanding of air sampling data. This review outlines many of the physical and environmental parameters that influence meaningful air sampling and recommends a simple procedure that has been tried and tested in many aspergillosis outbreaks. Copyright 2000 The Hospital Infection Society.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10662557     DOI: 10.1053/jhin.1999.0688

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  16 in total

1.  New respirable and fast dissolving itraconazole dry powder composition for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Pharm Res       Date:  2012-05-30       Impact factor: 4.200

2.  A study of air microbe levels in different areas of a hospital.

Authors:  Ginés Ortiz; Genoveva Yagüe; Manuel Segovia; Vicente Catalán
Journal:  Curr Microbiol       Date:  2009-03-28       Impact factor: 2.188

3.  Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.

Authors:  Marcie Tomblyn; Tom Chiller; Hermann Einsele; Ronald Gress; Kent Sepkowitz; Jan Storek; John R Wingard; Jo-Anne H Young; Michael J Boeckh; Michael A Boeckh
Journal:  Biol Blood Marrow Transplant       Date:  2009-10       Impact factor: 5.742

4.  Identification and seasonal distribution of airborne fungi in three horse stables in Italy.

Authors:  Simona Nardoni; Francesca Mancianti; Micaela Sgorbini; Fabrizio Taccini; Michele Corazza
Journal:  Mycopathologia       Date:  2005-08       Impact factor: 2.574

Review 5.  Pathogenesis of Aspergillus fumigatus in Invasive Aspergillosis.

Authors:  Taylor R T Dagenais; Nancy P Keller
Journal:  Clin Microbiol Rev       Date:  2009-07       Impact factor: 26.132

6.  Disruption of the Aspergillus fumigatus gene encoding nucleolar protein CgrA impairs thermotolerant growth and reduces virulence.

Authors:  Ruchi Bhabhra; Michael D Miley; Eleftherios Mylonakis; Doug Boettner; Jarrod Fortwendel; John C Panepinto; Michael Postow; Judith C Rhodes; David S Askew
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Successful pneumonectomy for invasive pulmonary aspergillosis and advanced non-small cell-lung cancer.

Authors:  Shohei Minesaki; Nobuyuki Koyama; Hironori Ishida; Kunihiko Kobayashi
Journal:  BMJ Case Rep       Date:  2013-03-14

8.  New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis.

Authors:  Christophe Duret; Nathalie Wauthoz; Thami Sebti; Francis Vanderbist; Karim Amighi
Journal:  Int J Nanomedicine       Date:  2012-10-18

9.  In vitro activity of disinfectants against Aspergillus spp.

Authors:  A S Mattei; I M Madrid; R Santin; L F D Schuch; M C A Meireles
Journal:  Braz J Microbiol       Date:  2013-10-30       Impact factor: 2.476

10.  Pollen and spore monitoring in the world.

Authors:  J T M Buters; C Antunes; A Galveias; K C Bergmann; M Thibaudon; C Galán; C Schmidt-Weber; J Oteros
Journal:  Clin Transl Allergy       Date:  2018-04-04       Impact factor: 5.871

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.